skip to Main Content

Study Finds almost Half of Patients with Inoperable Pancreatic Cancer are not Prescribed Essential Medication

Newsfeed image, light gray text on dark gray background

A University of Birmingham-led study has found almost half of people diagnosed within inoperable pancreatic cancer are not prescribed inexpensive yet essential tablets without which they cannot digest food – placing them at risk of starvation or being less able to tolerate treatment.

In light of the research findings, charity Pancreatic Cancer UK today (Wednesday 26 May) launches its ‘Transform Lives: Prescribe’ campaign, urging the NHS to ensure everyone who could benefit from the tablets, known as Pancreatic Enzyme Replacement Therapy (PERT), are prescribed them at the point of diagnosis. Read more . . . 

Back To Top